PELATON: A Drug Target / Disease Biomarker (G100506115)

Target Name: PELATON

NCBI ID: G100506115

PELATON

PELATON: A Drug Target / Disease Biomarker

PELATON is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. It is a member of the ELAV gene family, which is known for the production of housekeeping proteins that are involved in a variety of cellular processes. One of the unique features of PELATON is its ability to interact with other proteins, including the protein known as TCF-1, which is a critical regulator of cell growth and differentiation.

The research on PELATON has been focused on its potential role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Several studies have shown that PELATON is involved in the regulation of cellular processes that are critical for disease development, such as cell division, migration, and survival.

One of the most significant findings related to PELATON is its role in the development of cancer. Several studies have shown that PELATON is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. In addition, experiments have shown that inhibiting PELATON can lead to a reduction in the growth and survival of cancer cells. This suggests that PELATON may be a promising target for cancer therapies.

Another area of research related to PELATON is its role in neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles. Several studies have shown that PELATON is involved in the regulation of neurofibrillary tangles and the survival of brain cells. In addition, experiments have shown that targeting PELATON with drugs or other therapeutic agents may be a promising strategy for the treatment of neurodegenerative diseases.

In addition to its potential role in cancer and neurodegenerative diseases, PELATON is also being studied for its potential as a biomarker. Several studies have shown that the level of PELATON is highly correlated with the severity of neurodegenerative diseases, including Alzheimer's disease. In addition, experiments have shown that the level of PELATON is also highly correlated with the level of neurofibrillary tangles in brain cells, which is a hallmark of neurodegenerative diseases.

Overall, the study of PELATON has been significant in its ability to identify new targets for drug development and the treatment of various diseases. As more research is conducted on PELATON, it is likely that new treatments and therapies will be discovered that can improve the health and quality of life for individuals with these diseases.

Protein Name: Plaque Enriched LncRNA In Atherosclerotic And Inflammatory Bowel Macrophage Regulation

The "PELATON Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PELATON comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets